Rodolphe Janssens
Leveraging 15 years of rich experience in brand commercialization, digital development, and medical affairs in innovative pharmaceutical companies; in 2020, amid the COVID-19 pandemic, I stepped into the role of Commercial Operations Director at Gilead BeLux. This newly created position encompasses a broad scope across all therapeutic areas, ranging from digital and analytic transformation to commercial excellence and trade operations.
In this role, my focus is on translating global and local initiatives into actionable results, advancing our affiliate’s efficiency and competitiveness. Collaborative teamwork, problem-solving attitude, and influential leadership are key skills in steering change.
Rodolphe Janssens
Director Commercial Operations
Gilead
Friday 24 May
Learning of an Alchemist: Forging Gold From Lead in HCP Engagement Through Cross-Departmental Synergies. A Local Perspective.
Our journey of digital transformation within a biotech affiliate is somewhat akin to the work of an alchemist. It confronts the challenge of moving away from traditional practices towards a more innovative and efficient model. We aim to transform these 'lead' elements, like our entrenched practices and divergent priorities, into 'gold', thereby enhancing our competitiveness.
This presentation will share insights and reflections on fostering effective collaboration across departments, countries, and within the global/local framework. We will focus on the practical elements of transformation: how we can accelerate the transition, increase adoption of new capabilities, and emphasize that the true north of these changes are where it should always be: customer-centric.
° Setting the scene: a midsize market
° Product-centricity, customer-centricity and competitiveness
° Alchemy in action
° Translating with flexibility the global model
° Accelerators at local level
° From lead to gold: did the chemisty work?
Rodolphe Janssens
Director Commercial Operations
Gilead Sciences
